Late molecular recurrences in patients with chronic myeloid leukemia experiencing treatment-free remission

Key Points

• Late molecular recurrences after 2 years in patients with CML experiencing TFR represent 14% of all molecular recurrences.
• Patients with fluctuating minimal residual disease measurements during TFR are at high risk of late molecular recurrences.                                                                                                                                                                                   

https://ashpublications.org/bloodadvances/article/4/13/3034/461237/Late-molecular-recurrences-in-patients-with